Effects of cardiac support device on reverse remodeling: molecular, biochemical, and structural mechanisms

Area of Science:

• Cardiovascular Medicine
• Biomedical Engineering
• Heart Failure Research

Background:

• Progressive left ventricular (LV) dilation is a hallmark of heart failure with a poor prognosis.
• Understanding mechanisms to prevent LV enlargement is crucial for improving heart failure outcomes.

Purpose of the Study:

• To review the effects of the Acorn Cardiac Support Device (CSD) on preventing progressive LV dilation in dogs with chronic heart failure.
• To explore the cellular and functional mechanisms underlying CSD therapy's benefits.

Main Methods:

• Utilized observations from studies involving dogs with chronic heart failure treated with the Acorn Cardiac Support Device (CSD).
• Analyzed effects on LV dimensions, ejection fraction, shape, wall stress, and mitral regurgitation.
• Investigated cellular changes including cardiomyocyte hypertrophy, oxygen diffusion, protein expression, and calcium cycling.

Main Results:

• The CSD effectively prevented progressive LV dilation.
• Long-term CSD therapy improved LV ejection fraction, normalized LV shape, and reduced LV wall stress.
• CSD treatment attenuated cardiomyocyte hypertrophy, improved calcium cycling, and altered gene expression, contributing to enhanced LV function.

Conclusions:

• The Acorn Cardiac Support Device (CSD) demonstrates significant efficacy in preventing left ventricular dilation and improving cardiac function in a canine model of heart failure.
• CSD therapy offers a promising approach by addressing both the mechanical and cellular aspects of heart failure progression.
• The findings provide mechanistic insights into how mechanical support can reverse adverse cardiac remodeling and improve systolic function.